List today: Adherex Technologies FENC is a clinical-stage biotechnology company which is focused on the development of Sodium ...

Shares of mid-cap oncology specialist Exelixis are worth about $39 each right now. The biotech generates steady revenue and ...

Biotech investing is often a high-risk, high-reward game, with clinical trial results capable of sending stocks soaring or ...

Healthcare and biotech stocks have lagged broader markets this year, but a growing number of names have been picking up steam ...

The shares of Sheel Biotech made a strong debut on stock markets on October 8, listing at Rs 91 apiece on the NSE Emerge ...

This year’s A-List shows that the revenues for the top five public companies in spatial biology have risen nine percent from a year ago ...

The ground shifted under China’s drugmakers when volume-based procurement cut through list prices. Margins tightened, business models wobbled, and strategy decks were rewritten overnight. The domestic ...

Summit Therapeutics Inc. (NASDAQ: SMMT) is one of the best biotech stocks with high potential. In a report released on ...

Many of the biotech stocks remain outside of Mr. Market's interest zone. Check out five biotech firms that may be of interest ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Biotech is outperforming the S&P 500 and NASDAQ as M&A heats up and Q4 tailwinds emerge, signaling more upside ahead. Read ...

More than 200 private U.S. biotechs with $50 million or more in funding to date secured their last reported financing between ...